News Image

Cyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Nov 12, 2024

BERKELEY HEIGHTS, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced third quarter financial results and provided a business update.

Read more at globenewswire.com

CYCLACEL PHARMACEUTICALS INC

NASDAQ:CYCC (7/24/2025, 9:48:09 AM)

17.3

+3.3 (+23.57%)


CYCLACEL PHARMACEUTICALS - CYCC 6 PERP

NASDAQ:CYCCP (7/23/2025, 8:14:48 PM)

Premarket: 5.09 +0.44 (+9.46%)

4.65

-0.34 (-6.81%)



Find more stocks in the Stock Screener

CYCC Latest News and Analysis

Follow ChartMill for more